Venous malformation of the tongue in a child treated by sclerotherapy with ethanolamine oleate: a case report

Nishikawa, Masanori; Sakamoto, Kouzo; Hidaka, Miyoko; Yamashita, Akihiro; Yamamoto, Gaku

doi:10.1016/j.jpedsurg.2005.12.030

Cited by 17 publications

(12 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…22 EO is also used for CVMs, and effective result has been also reported with the use of EO. 23,24 EO is a salt of an unsaturated fatty acid and has been commonly used for the treatment of esophageal and gastric varices as a sclerosing agent because it has excellent thrombosing properties.…”

Section: Discussionmentioning

confidence: 99%

Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations

Yamaki

Nozaki

Sakurai

et al. 2008

Journal of Vascular Surgery

148

105

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations

Yamaki

Nozaki

Sakurai

et al. 2008

Journal of Vascular Surgery

148

105

View full text Add to dashboard Cite

show abstract

“…5 The agents for sclerotherapy are 5% Sodium Morruhate, 1% Polidocal, Sodium Tertradecil Sulfate, Absolute Alcohol and 5% Ethanol Amine Oleate. 6 No clinical studies are found which compare the effectiveness of various sclerosing agents.…”

mentioning

confidence: 99%

Effectiveness of Sclerotherapy with Ethanol Amine Oleate in Benign Oral and Perioral Vascular Lesions

Pradhan

Rahman

2011

Bangabandhu Sheikh Mujib Medical Univ J

View full text Add to dashboard Cite

“…These are not as potent as absolute alcohol, but their risk profile is excellent and repeat procedures yield good outcomes . Ethanolamine has also been used, but may elicit red blood cell hemolysis, which requires administration of haptoglobin to prevent renal damage . Sodium morrhuate has also been used with good results.…”

Section: Discussionmentioning

confidence: 99%

Ultrasound‐guided polidocanol foam sclerotherapy for treating venous malformations

Kumar

Bhavana

Kumar

et al. 2017

J of Clinical Ultrasound

View full text Add to dashboard Cite

Aim: To evaluate clinical and imaging outcomes after ultrasound (US)-guided 3% polidocanol (POL) foam-sclerotherapy of venous malformations (VMs). Methods:We retrospectively evaluated consecutive VM cases over 1.5 years, with 6-month follow-up. US findings were used to classify VMs into four types depending upon extent of anechoic channels, connections to adjacent veins, and dysmorphism. Single or multiple needles were inserted depending upon lesion size, and used to inject up to 8 mL POL per session, every 2 to 4 weeks. We evaluated reduction in pain and swelling, lesion resolution on imaging, and patient satisfaction.Results: There were 15, 24, 9, and 5 patients (total 53) with type I, II, III, and IV VMs, respectively.The average number of sessions was 5.3, 4.3, and 4, and the average amount of POL injected was 14.24 mL, 16.1 mL, and 23.2 mL for type I, II, III VMs, respectively. The number of sessions correlated with lesion volume (P < .0001). Imaging showed good resolution in 4/15, 18/24, 6/9, and 4/ 5 patients respectively with type I, II, III, and IV VMs. Patient satisfaction was not related to lesion type (P 5 .1). ROC analyses showed cut-off values of 4.9 mL lesion volume, three sessions, and 12 mL POL volume for patient satisfaction. At 6 months, 23 patients having pain had significant improvement (P < .00001). Local (n 5 30) and chest pain (n 5 2) were the only complications.Conclusions: US-guided sclerotherapy with 3% POL foam is safe and effective. Lesions with up to 50% anechoic areas had better resolution, without correlation with patient satisfaction. We used foam made by agitating 3% POL with room air, and performed the sclerotherapy under US guidance. We evaluated the clinical and radiological results in a series of consecutive patients.

show abstract

Venous malformation of the tongue in a child treated by sclerotherapy with ethanolamine oleate: a case report

Cited by 17 publications

References 5 publications

Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations

Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations

Effectiveness of Sclerotherapy with Ethanol Amine Oleate in Benign Oral and Perioral Vascular Lesions

Ultrasound‐guided polidocanol foam sclerotherapy for treating venous malformations

Contact Info

Product

Resources

About